Navigation Links
New FDA regulations puts some cough syrups off market

The Food and Drug Administration's(FDA) new effort to re-examine very old drugs that began selling before the government ever required proof that drugs worked well, has landed dozens of brands of prescription cough syrup in trouble. Until now FDA stressed that the expectorant, extended-release guaifenesin, is not dangerous. However, the recent crackdown lead to the FDA formally approving sale of Adams// Laboratories' Mucinex, making competing companies' unapproved versions automatically illegal. The FDA has warned 66 manufacturers that Mucinex would be the only once-a-day prescription guaifenesin allowed to sell unless its competitors won formal approval. The FDA has given these companies time till end of November to pull their brands of extended-release guaifenesin off the market.


Page: 1

Related medicine news :

1. Avenues to opened for medical tourists following relaxation of visa regulations
2. Hostility breeds against Homeopathy in England following new regulations
3. Negligent doctors asked to cough up 3 lakhs for death of patient
4. Iron supplements proves helpful in dry cough .
5. Hypertensive drugs may cause cough
6. Sensitive cough suffered by females
7. How to arrest cough
8. Chronic cough can lead to depression
9. High Incidence of Whooping cough
10. Australia coughs up $15m to resurrect Lebanon
11. Indias anti-AIDS drug market engaged in price war
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I ... regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order ... developed the patent-pending RECOVERY BRA for added comfort and support. The bra is ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... on providing comprehensive solutions involving adult stem cell therapies to patients with chronic ... the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required to ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Dr. Todd S. ... offer laser services to many of his patients. Dr. Afferica now uses the BIOLASE ... reduce the amount of time the doctor uses other traditional cutting tools, such as ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article published ... that determine which patients are or are not eligible for bariatric surgery. The article ... over 40, are more than 100 pounds overweight, or have a BMI of 35 ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 ... --> adds Latest Guidebook for ... of 217 pages published in November 2015 to ... online business intelligence library at . ... of the fastest growing global economies with a ...
(Date:11/24/2015)... 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ASDS ... of Directors has declared a special 1 percent stock dividend ... payable December 14, 2015, to shareholders of record December 7, ... additional shares of common stock. --> ... a strong endorsement of our confidence in Ascendant,s growth strategy ...
(Date:11/24/2015)... Nov. 24, 2015 Diplomat Pharmacy, Inc. (NYSE: DPLO) ... of Clinical Services, Education and Human Resources will be presenting ... Oncology Drugs: Health Plan Strategies for a Dynamic Market" on ... Fenrick , a consultant with the Cambridge Advisory Group, where ... The webinar will discuss the rapid growth ...
Breaking Medicine Technology: